APPB — Applied Biosciences Income Statement
0.000.00%
Last trade - 00:00
HealthcareHighly SpeculativeMicro Cap
2015 March 31st | 2016 March 31st | 2017 March 31st | 2018 March 31st | 2019 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0 | 0 | 0.046 | 0.198 | 0.707 |
Cost of Revenue | |||||
Gross Profit | — | — | 0.039 | 0.042 | 0.185 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 0.017 | 0.028 | 0.561 | 2.58 | 3.35 |
Operating Profit | -0.017 | -0.028 | -0.516 | -2.39 | -2.65 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | -0.017 | -0.028 | -0.516 | -2.39 | -2.68 |
Net Income After Taxes | -0.017 | -0.028 | -0.516 | -2.39 | -2.68 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | -0.017 | -0.028 | -0.518 | -2.38 | -2.63 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -0.017 | -0.028 | -0.518 | -2.38 | -2.63 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.022 | -0.001 | -0.012 | -0.098 | -0.221 |
Dividends per Share |